Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (99)	4/17/1999 6:20:00 PM
From: sim1	Read Replies (3) \| Respond to of 555

Drug Discovery Technology 1999 August 16-19, 1999 · The Seaport Hotel & World Trade Center · Boston, MA drugdisc.com Keynote Presentations Leroy Hood, M.D., Ph.D., Gates Professor and Chairman, Department of Molecular Biotechnology, University of Washington (PLUS PHOTO) Title of Presentation: "Lessons from the Human Genome Project: A Revolution in Biology and Medicine of the 21st Century" Michael Pavia, Ph.D., Chief Technology Development Officer, Millennium Pharmaceuticals, Inc. (PLUS PHOTO) Title of Presentation: Millennium's Integrated Technology Platforms for Improving Drug Discovery and Development" George Poste, Ph.D., Chief Science and Technology Officer, SmithKline Beecham Pharmaceuticals (PLUS PHOTO) Title of presentation: "Re-Engineering R&D for the Next Millennium" Stuart L. Schreiber, Ph.D., Co-Director, Harvard Institute of Chemistry & Cell Biology, Harvard University (PLUS PHOTO) Title of Presentation: "Specificity and Generality in Chemical Genetic Research" Monday, August 16, 1999 7:30 Morning Pre-Conference Symposium Registration Pre-Conference Symposia - [optional, choose from list] 8:30-12:00 Toxicity Prediction in Drug Discovery 1:30-5:30 Overcoming Key Bottlenecks in the Drug Discovery Cascade 1:30-5:30 Strategic Alliances and Collaborations in Research and Pre-Clinical Development 5:30-8:00 Opening Night Networking Reception Tuesday, August 17, 1999 6:30 Main Conference Registration 8:00-9:30 Keynote Presentations Stuart L. Schreiber, Ph.D., Harvard University George Poste, Ph.D., SmithKline Beecham Pharmaceuticals Conference Tracks - [choose a track] 10:15-12:50 Parallel Sessions Track 1: Target Discovery and Validation through Genomics Track 2: Miniaturization and Biochip Technologies 12:50-3:00 Poster/Exhibit Viewing and Lunch in the Exhibit Hall Technology Workshops - [choose one from each group] 3:00-4:00 Molecular Devices Pangea Systems PE Biosystems 4:15-5:15 CCS Packard Ciphergen Corning 5:15-7:45 Networking Reception Wednesday, August 18, 1999 8:10-9:35 Keynote Presentations Leroy Hood, M.D., Ph.D., University of Washington Michael Pavia, Ph.D., Millennium Pharmaceuticals, Inc. 10:20-12:25 Track 1: Chemistries and Synthesis Techniques Track 2: High-Throughput Screening 12:25-2:25 Poster/Exhibit Viewing and Lunch in the Exhibit Hall 2:25-6:00 Track 1: Protein Technologies AND Lead Discovery and Optimization Track 2: Bioinformatics AND Integrating Technologies 6:30 New England Clambake Thursday, August 19, 1999 8:15-12:00 Drug Discovery Case Histories 12:00 Close of Drug Discovery Technology '99 American Chemical Society Short Courses - [optional] 12:10 Registration for American Chemical Society Short Courses 12:30-6:00 American Chemical Society Short Courses Organic Chemistry of Drug Design and Drug Action Drug Discovery Using Molecular Biology Techniques to Find Drug Targets Synthetic Organic Chemistry: Modern Methods and Strategies Friday, August 20, 1999 8:00-5:00 American Chemical Society Short Courses Continue